No­vavax plots to re­duce Eu­ro­pean foot­print to be­come a ‘lean­er’ com­pa­ny

No­vavax is “ac­tive­ly ex­plor­ing” to di­vest its man­u­fac­tur­ing fa­cil­i­ty in the Czech Re­pub­lic as the com­pa­ny con­tin­ues to face dwin­dling de­mand for its vac­cines, CFO …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER